Publications by authors named "Afruj Ruf"

We describe a novel deletion causing εγδβ thalassemia in a Pakistani family. The Pakistani deletion is 506kb in length, and the second largest εγδβ thalassemia deletion reported to date. It removes the entire β globin gene (HBB) cluster, extending from 431kb upstream to 75kb downstream of the ε globin gene (HBE).

View Article and Find Full Text PDF

Background: Alterations of the p53 gene at 17p13.1 as well as the gene for a transmembrane p-glycoprotein, ABCB1 (MDR-1) at 7q21.12, have been shown to be mostly associated with the phenomenon of multi-drug resistance (MDR) in human cancers.

View Article and Find Full Text PDF
Article Synopsis
  • P-Glycoprotein helps control the levels of chemotherapy drugs in both normal and cancer cells, and this study focuses on using verapamil as an antagonist to combat drug resistance in non-Hodgkin's lymphoma (NHL) cells that over-express a mutated p53 protein.
  • The study utilized the single cell gel electrophoresis (SCGE) assay to measure DNA damage in leucocytes from NHL patients and Raji cell lines, showing changes in DNA damage across different cell types influenced by P-glycoprotein.
  • Results indicated that verapamil enhanced DNA damage in p53 mutant cells treated with doxorubicin, suggesting that the SCGE assay could be a reliable method for evaluating P
View Article and Find Full Text PDF

Thalassaemia is an inherited group of disorders caused by a reduction or total absence of one or more of the globin chains of the haemoglobin molecule. It has been shown that lymphocytes isolated from a sickle/beta thal double heterozygote-sickle phenotype patient showed increased sensitivity to the dietary food mutagen 3-amino-1-methyl-5H-pyridol(4,3-b)indole (Trp-P-2) when compared to the control. Furthermore, when a combination of Trp-P-2 with either quercitin or kaempferol was compared, the responses to Trp-P-2 were reduced to untreated control levels at the highest doses of quercitin and kaempferol.

View Article and Find Full Text PDF

Thalassaemia is a heterogeneous group of inherited anaemias, characterised by a reduction or total absence of one or more of the globin chains of haemoglobin. Individuals with thalassaemia major require regular blood transfusions in order to maintain their haemoglobin concentration at an appropriate level. An essential treatment in parallel with transfusions is iron chelation therapy to remove excess iron deposited in tissues from the transfused blood.

View Article and Find Full Text PDF